Goldman Sachs Group Inc Relay Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,975,465 shares of RLAY stock, worth $8.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,975,465
Previous 1,484,518 33.07%
Holding current value
$8.81 Million
Previous $9.68 Million 44.5%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$6.23 - $9.51 $3.06 Million - $4.67 Million
490,947 Added 33.07%
1,975,465 $14 Million
Q2 2024

Aug 13, 2024
SELL
$5.9 - $8.02 $1.64 Million - $2.23 Million
-278,630 Reduced 15.8%
1,484,518 $9.68 Million
Q1 2024

May 15, 2024
BUY
$7.5 - $12.07 $5.85 Million - $9.41 Million
779,761 Added 79.29%
1,763,148 $14.6 Million
Q4 2023

Feb 13, 2024
BUY
$6.01 - $11.48 $551,609 - $1.05 Million
91,782 Added 10.29%
983,387 $10.8 Million
Q3 2023

May 14, 2024
SELL
$8.24 - $12.97 $756,283 - $1.19 Million
-91,782 Reduced 9.33%
891,605 $7.5 Million
Q3 2023

Nov 14, 2023
SELL
$8.24 - $12.97 $3.28 Million - $5.16 Million
-397,846 Reduced 30.85%
891,605 $7.5 Million
Q2 2023

May 14, 2024
SELL
$9.99 - $18.27 $1.1 Million - $2 Million
-109,648 Reduced 7.84%
1,289,451 $16.2 Million
Q2 2023

Aug 14, 2023
SELL
$9.99 - $18.27 $1.1 Million - $2 Million
-109,648 Reduced 7.84%
1,289,451 $16.2 Million
Q1 2023

May 14, 2024
BUY
$15.0 - $22.76 $1.89 Million - $2.86 Million
125,684 Added 9.87%
1,399,099 $23 Million
Q1 2023

May 11, 2023
BUY
$15.0 - $22.76 $1.89 Million - $2.86 Million
125,684 Added 9.87%
1,399,099 $23 Million
Q4 2022

May 14, 2024
SELL
$14.16 - $24.02 $2.16 Million - $3.67 Million
-152,888 Reduced 10.72%
1,273,415 $19 Million
Q4 2022

Feb 13, 2023
SELL
$14.16 - $24.02 $2.16 Million - $3.67 Million
-152,888 Reduced 10.72%
1,273,415 $19 Million
Q3 2022

May 14, 2024
BUY
$18.07 - $31.37 $8.43 Million - $14.6 Million
466,520 Added 48.61%
1,426,303 $31.9 Million
Q3 2022

Nov 10, 2022
BUY
$18.07 - $31.37 $8.43 Million - $14.6 Million
466,520 Added 48.61%
1,426,303 $31.9 Million
Q2 2022

May 14, 2024
SELL
$13.31 - $34.88 $314,169 - $823,307
-23,604 Reduced 2.4%
959,783 $16.1 Million
Q2 2022

Aug 15, 2022
BUY
$13.31 - $34.88 $8.77 Million - $23 Million
659,012 Added 219.11%
959,783 $16.1 Million
Q1 2022

May 16, 2022
SELL
$20.26 - $32.36 $2.88 Million - $4.6 Million
-142,230 Reduced 32.11%
300,771 $9 Million
Q4 2021

Feb 14, 2022
BUY
$26.0 - $37.03 $7.37 Million - $10.5 Million
283,420 Added 177.6%
443,001 $13.6 Million
Q3 2021

Nov 10, 2021
BUY
$29.75 - $37.99 $4.75 Million - $6.06 Million
159,581 New
159,581 $5.03 Million

Others Institutions Holding RLAY

# of Institutions
204
Shares Held
156M
Call Options Held
207K
Put Options Held
40K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $536M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email